NASDAQ : MBAI
Check-Cap Ltd. — Financial statements
Healthcare · Diagnostics & Research · Israel
Last price 2.09 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 31.96M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Check-Cap Ltd. (MBAI) reported revenue of 2.33M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Revenue | 2.33M | 2.33M | 191.76K |
| Cost of Revenue | 1.05M | 1.05M | 181.80K |
| Gross Profit | 1.29M | 1.29M | 9.96K |
| Selling, General & Admin | 721.46K | 721.46K | 4.44K |
| Operating Expenses | 790.56K | 790.56K | 4.44K |
| Operating Income | 498.30K | 498.30K | 5.52K |
| Interest Expense | -12.38K | -12.38K | |
| Interest & Investment Income | 65.56K | 65.56K | |
| Pretax Income | 551.48K | 551.48K | 5.52K |
| Income Tax Expense | 43.63K | 43.63K | 1.16K |
| Net Income | 507.85K | 507.85K | 4.36K |
| Net Income to Common | 507.85K | 507.85K | 4.36K |
| Shares Outstanding (Basic) | 21.48M | 21.48M | 5.13M |
| Shares Outstanding (Diluted) | 21.48M | 21.48M | 5.13M |
| EPS (Basic) | 0.02 | 0.02 | |
| EPS (Diluted) | 0.02 | 0.02 | |
| Free Cash Flow | -1.21M | -1.21M | -356.91K |
| Free Cash Flow Per Share | -0.06 | -0.06 | -0.07 |
| Gross Margin | 55.20% | 55.20% | 5.19% |
| Operating Margin | 21.34% | 21.34% | 2.88% |
| Profit Margin | 21.75% | 21.75% | 2.27% |
| Free Cash Flow Margin | -51.74% | -51.74% | -186.12% |
| EBITDA | 567.40K | 567.40K | |
| EBITDA Margin | 24.30% | 24.30% | |
| D&A For EBITDA | 69.10K | 69.10K | |
| EBIT | 498.30K | 498.30K | 5.52K |
| EBIT Margin | 21.34% | 21.34% | 2.88% |
| Effective Tax Rate | 7.91% | 7.91% | 21.03% |
| Revenue as Reported | 2.33M | 2.33M | 191.76K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Cash & Equivalents | 799.47K | 799.47K | 94.33K |
| Cash & Short-Term Investments | 799.47K | 799.47K | 94.33K |
| Accounts Receivable | 824.84K | 824.84K | |
| Receivables | 840.84K | 840.84K | |
| Inventory | 75.93K | ||
| Other Current Assets | 14.67K | ||
| Total Current Assets | 1.64M | 1.64M | 184.94K |
| Property, Plant & Equipment | 545.99K | 545.99K | |
| Long-Term Accounts Receivable | 1.26M | 1.26M | |
| Total Assets | 3.45M | 3.45M | 184.94K |
| Accounts Payable | 139.05K | 139.05K | |
| Accrued Expenses | 259.57K | 259.57K | 290.00 |
| Short-Term Debt | 416.00K | 416.00K | 183.20K |
| Total Current Liabilities | 814.62K | 814.62K | 183.49K |
| Long-Term Deferred Tax Liabilities | 43.63K | 43.63K | |
| Total Liabilities | 858.24K | 858.24K | 183.49K |
| Common Stock | 1.53K | 1.53K | 359.00 |
| Additional Paid-In Capital | 2.08M | 2.08M | |
| Retained Earnings | 508.94K | 508.94K | 1.09K |
| Shareholders' Equity | 2.59M | 2.59M | 1.45K |
| Total Liabilities & Equity | 3.45M | 3.45M | 184.94K |
| Total Debt | 416.00K | 416.00K | 183.20K |
| Net Cash (Debt) | 383.47K | 383.47K | -88.87K |
| Net Cash Per Share | 0.02 | 0.02 | -0.02 |
| Filing Date Shares Outstanding | 21.91M | 21.91M | 5.13M |
| Total Common Shares Outstanding | 21.91M | 21.91M | 5.13M |
| Working Capital | 825.69K | 825.69K | 1.45K |
| Book Value Per Share | 0.12 | 0.12 | 0.00 |
| Tangible Book Value | 2.59M | 2.59M | 1.45K |
| Tangible Book Value Per Share | 0.12 | 0.12 | 0.00 |
| Machinery | 615.08K | 615.08K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Net Income | 507.85K | 507.85K | 4.36K |
| Depreciation & Amortization | 69.10K | 69.10K | |
| Other Operating Activities | -1.85M | -1.85M | |
| Change in Inventory | 75.93K | 75.93K | -303.74K |
| Change in Accounts Payable | 398.33K | 398.33K | 1.16K |
| Change in Other Net Operating Assets | 204.83K | 204.83K | -58.69K |
| Operating Cash Flow | -593.00K | -593.00K | -356.91K |
| Capital Expenditures | -615.08K | -615.08K | |
| Other Investing Activities | 1.33K | 1.33K | |
| Investing Cash Flow | -613.75K | -613.75K | |
| Total Debt Issued | 732.81K | ||
| Short-Term Debt Repaid | -167.20K | -167.20K | |
| Total Debt Repaid | -167.20K | -167.20K | |
| Net Debt Issued (Repaid) | -167.20K | -167.20K | 732.81K |
| Issuance of Common Stock | 2.08M | 2.08M | 1.44K |
| Financing Cash Flow | 1.91M | 1.91M | 734.24K |
| Net Cash Flow | 705.13K | 705.13K | 377.33K |
| Free Cash Flow | -1.21M | -1.21M | -356.91K |
| Free Cash Flow Margin | -51.74% | -51.74% | -186.12% |
| Free Cash Flow Per Share | -0.06 | -0.06 | -0.07 |
| Levered Free Cash Flow | -594.19K | -594.19K | |
| Unlevered Free Cash Flow | -586.45K | -586.45K | |
| Change in Working Capital | 679.09K | 679.09K | -361.27K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Last Close Price | 1.88 | 11.34 | 6.93 |
| Debt / Equity Ratio | 0.16 | 0.16 | 126.52 |
| Debt / EBITDA Ratio | 0.73 | 0.73 | |
| Net Debt / Equity Ratio | -0.15 | -0.15 | 61.37 |
| Net Debt / EBITDA Ratio | -0.68 | -0.68 | |
| Net Debt / FCF Ratio | 0.32 | 0.32 | -0.25 |
| Asset Turnover | 1.29 | 1.29 | |
| Quick Ratio | 1.99 | 1.99 | 0.51 |
| Current Ratio | 2.01 | 2.01 | 1.01 |
| Return on Equity (ROE) | 39.22% | 39.22% | |
| Return on Assets (ROA) | 17.15% | 17.15% | |
| Return on Invested Capital (ROIC) | 39.98% | 39.98% | 4.82% |
| Return on Capital Employed (ROCE) | 18.90% | 18.90% | 380.90% |
| Buyback Yield / Dilution | -318.79% |